Prediction of Response to Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients with Active Psoriatic Arthritis

被引：0
|
作者：
de Vlam, Kurt [1 ]
Coates, Laura [2 ]
Ogdie, Alexis [3 ]
Helliwell, Philip [4 ]
van der Heijde, Desiree [5 ]
Gladman, Dafna [6 ,7 ]
Wang, Cunshan [8 ]
Wu, Joseph [8 ]
Fallon, Lara [9 ]
机构：
[1] UZ Leuven, Leuven, Belgium
[2] Univ Oxford, Oxford, England
[3] Univ Penn, Dept Med, Perelman Sch Med, Div Rheumatol, Philadelphia, PA 19104 USA
[4] Univ Leeds, Leeds, W Yorkshire, England
[5] Leiden Univ, Med Ctr, Leiden, Netherlands
[6] Toronto Western Hosp, Toronto, ON, Canada
[7] Univ Toronto, Toronto, ON, Canada
[8] Pfizer Inc, Groton, CT 06340 USA
[9] Pfizer Canada Inc, Montreal, PQ, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2019年 / 46卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
218
引用
收藏
页码：848 / 848
页数：1
相关论文
共 50 条
  • [1] Integrated Efficacy Analysis of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients with Active Psoriatic Arthritis
    Nash, Peter
    Coates, Laura C.
    Fleischmann, Roy
    Papp, Kim
    Gomez-Reino, Juan J.
    Kanik, Keith S.
    Wang, Cunshan
    Wu, Joseph
    Hendrikx, Thijs
    Ports, William C.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [2] INTEGRATED EFFICACY ANALYSIS OF TOFACITINIB, AN ORAL JANUS KINASE INHIBITOR, IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
    Nash, P.
    Coates, L. C.
    Fleischmann, R.
    Papp, K. A.
    Gomez-Reino, J. J.
    Kanik, K. S.
    Wang, C.
    Wu, J.
    Hendrikx, T.
    Ports, W. C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 951 - 952
  • [3] Tofacitinib: A novel oral Janus kinase inhibitor for rheumatoid arthritis
    O'Dell, Kate M.
    Rummel, Ashley E.
    [J]. FORMULARY, 2012, 47 (10) : 350 - +
  • [4] Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
    Sandborn, William J.
    Ghosh, Subrata
    Panes, Julian
    Vranic, Ivana
    Su, Chinyu
    Rousell, Samantha
    Niezychowski, Wojciech
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (07): : 616 - 624
  • [5] Effects Of Tofacitinib, An Oral Janus Kinase Inhibitor, On Work Limitations In Patients With Rheumatoid Arthritis
    Strand, Vibeke
    Kanik, Keith S.
    Connell, Carol
    Wilkinson, Bethanie
    Gruben, David
    Wallenstein, Gene
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S1002 - S1002
  • [6] Cardiovascular safety findings in patients with rheumatoid arthritis treated with tofacitinib, an oral Janus kinase inhibitor
    Charles-Schoeman, Christina
    Wicker, Pierre
    Gonzalez-Gay, Miguel A.
    Boy, Mary
    Zuckerman, Andrea
    Soma, Koshika
    Geier, Jamie
    Kwok, Kenneth
    Riese, Richard
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2016, 46 (03) : 261 - 271
  • [7] The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis
    Hodge, J. A.
    Kawabata, T. T.
    Krishnaswami, S.
    Clark, J. D.
    Telliez, J. -B.
    Dowty, M. E.
    Menon, S.
    Lamba, M.
    Zwillich, S.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (02) : 318 - 328
  • [8] TOFACITINIB, AN ORAL JANUS KINASE INHIBITOR, IN THE TREATMENT OF RHEUMATOID ARTHRITIS - THE RESULTS OF RUSSIAN NATIONAL REGISTER OF PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TOFACITINIB
    Gaydukova, Inna
    Mazurov, V.
    Zhilyaev, Evgeniy
    Grabovetskaya, Iuliia
    Marusenko, Irina
    Vasilenko, Elizaveta
    Abdulganieva, Diana
    Smitienko, Ilia
    Misiyuk, Anna
    Lukina, Galina
    Knyazeva, Larisa
    Kalinina, Elena
    Samigullina, Ruzana
    Bondareva, Irina
    Yudina, Natalya
    Lapkina, N.
    Nasonov, Evgeny
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 359 - 360
  • [9] Efficacy and Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, or Adalimumab in Patients with Active Psoriatic Arthritis and an Inadequate Response to Conventional Synthetic Dmards: A Randomized, Placebo-Controlled, Phase 3 Trial
    Mease, Philip J.
    Hall, Stephen
    FitzGerald, Oliver
    van der Heijde, Desiree
    Merola, Joseph F.
    Avila-Zapata, Francisco
    Cieslak, Dorata
    Graham, Daniela
    Wang, Cunshan
    Menon, Sujatha
    Hendrikx, Thijs
    Kanik, Keith
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [10] Cardiovascular Safety Findings In Rheumatoid Arthritis Patients Treated With Tofacitinib, A Novel, Oral Janus Kinase Inhibitor
    Charles-Schoeman, C.
    Wicker, P.
    Gonzalez-Gay, M. A.
    Wood, S. P.
    Boy, M. G.
    Geier, J.
    Gruben, D.
    Soma, K.
    Riese, R.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S191 - S191
12345